Posts

FDA makes acting CBER and CDER leaders permanent

on

FDA Makes CDER and CBER Leadership Permanent While Commissioner Nominee Awaits Senate Confirmation

on

CDER chief Høeg, skeptic of vaccines and antidepressants, is fired in high-level FDA shakeup

on

High Turnover in Top FDA and CDC Roles: 15 Leaders in 18 Months Amid Leadership Instability

on

FDA names Tracy Beth Heg as acting CDER chief

on

FDA Breakthrough Designations Lead to Priority Reviews, Report Finds

on

Can the CDER-CBER Dynamic Change Under New Leadership? Pazdur vs. Prasad in the FDA’s Turbulent 2025

on

FDA Staffing Data Reveal Historic Departures in Fiscal 2025

on

FDA Drug Approvals in 2025 Remain Within Recent Averages Amid Agency Upheaval

on

FDA Launches New Submission Program for Rare Disease Gene Therapies via CDER and CBER

on

FDA Seeks Greater Alignment Between CBER and CDER: Makary Informs Industry Leaders

on

CDER Employees Leave FDA in Droves Amid HHS Overhaul

on

FDA Acting CDER Head Jacqueline Corrigan-Curay to Retire Amid Leadership Turnover

on

About 5% of CBER and CDER Left After FDA Staff Cuts, Analysis Finds

on